Literature DB >> 7971280

NF-kappa B-independent activation of beta-interferon expression in mouse F9 embryonal carcinoma cells.

M J Ellis1, S Goodbourn.   

Abstract

We have examined the behaviour of the beta-interferon promoter in mouse F9 embryonal carcinoma cells. In undifferentiated cells, the beta-interferon promoter is not responsive to dsRNA or to Sendai virus. In cells stimulated to differentiate into parietal endoderm by treatment with retinoic acid, the beta-interferon promoter responds to both inducers, but only Sendai virus can activate the transcription factor NF-kappa B previously thought to be essential for beta-interferon induction. Differentiated F9 cells therefore present an unprecedented situation in which induction of the beta-interferon gene does not require NF-kappa B. In addition to these differences, induction by dsRNA, but not by Sendai virus, is significantly enhanced by a pretreatment with interferon (priming). These observations suggest that paramyxo-viruses can participate in beta-interferon induction in a manner that is distinct from a simple generator of dsRNA. Analysis of the promoter requirements for induction in differentiated F9 cells suggests that induction is brought about by a novel mechanism using the currently identified regulatory domains.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7971280      PMCID: PMC308484          DOI: 10.1093/nar/22.21.4489

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  49 in total

1.  Absence of the type I IFN system in EC cells: transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated.

Authors:  H Harada; K Willison; J Sakakibara; M Miyamoto; T Fujita; T Taniguchi
Journal:  Cell       Date:  1990-10-19       Impact factor: 41.582

2.  Multimerization of AAGTGA and GAAAGT generates sequences that mediate virus inducibility by mimicking an interferon promoter element.

Authors:  D Näf; S E Hardin; C Weissmann
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

3.  A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo.

Authors:  M H Rosner; M A Vigano; K Ozato; P M Timmons; F Poirier; P W Rigby; L M Staudt
Journal:  Nature       Date:  1990-06-21       Impact factor: 49.962

4.  A ubiquitous repressor interacting with an F9 cell-specific silencer and its functional suppression by differentiated cell-specific positive factors.

Authors:  K Furukawa; Y Yamaguchi; E Ogawa; K Shigesada; M Satake; Y Ito
Journal:  Cell Growth Differ       Date:  1990-03

5.  The involvement of NF-kappa B in beta-interferon gene regulation reveals its role as widely inducible mediator of signal transduction.

Authors:  M J Lenardo; C M Fan; T Maniatis; D Baltimore
Journal:  Cell       Date:  1989-04-21       Impact factor: 41.582

6.  Expression of the K-fgf protooncogene is repressed during differentiation of F9 cells.

Authors:  A Velcich; P Delli-Bovi; A Mansukhani; E B Ziff; C Basilico
Journal:  Oncogene Res       Date:  1989

7.  Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes.

Authors:  H Harada; T Fujita; M Miyamoto; Y Kimura; M Maruyama; A Furia; T Miyata; T Taniguchi
Journal:  Cell       Date:  1989-08-25       Impact factor: 41.582

8.  Proteolytic degradation of MAD3 (I kappa B alpha) and enhanced processing of the NF-kappa B precursor p105 are obligatory steps in the activation of NF-kappa B.

Authors:  K H Mellits; R T Hay; S Goodbourn
Journal:  Nucleic Acids Res       Date:  1993-11-11       Impact factor: 16.971

9.  Control of beta-interferon expression in murine embryonal carcinoma F9 cells.

Authors:  M K Francis; J M Lehman
Journal:  Mol Cell Biol       Date:  1989-08       Impact factor: 4.272

10.  Double-stranded RNA activates binding of NF-kappa B to an inducible element in the human beta-interferon promoter.

Authors:  K V Visvanathan; S Goodbourn
Journal:  EMBO J       Date:  1989-04       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.